Edinburgh Research Explorer

Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancer

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1438-44
Number of pages7
JournalClinical Cancer Research
Volume13
Issue number5
DOIs
Publication statusPublished - 1 Mar 2007

Abstract

This study sought to explore the predictive value of the insulin-like growth factor (IGF) binding proteins (IGFBP) as markers of response in ovarian cancer patients treated with the aromatase inhibitor letrozole.

    Research areas

  • Antineoplastic Agents, CA-125 Antigen, Cell Line, Tumor, Drug Resistance, Neoplasm, Estradiol, Female, Humans, Immunohistochemistry, Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor Binding Protein 4, Insulin-Like Growth Factor Binding Protein 5, Insulin-Like Growth Factor Binding Proteins, Nitriles, Ovarian Neoplasms, RNA, Messenger, Receptors, Estrogen, Reverse Transcriptase Polymerase Chain Reaction, Triazoles

ID: 8767480